Genetic testing in congenital heart disease:A clinical approach

• Published in: World journal of cardiology Vol. 8; no. 2; pp. 180 - 191
• Main Authors: Chaix, Marie A, Andelfinger, Gregor, Khairy, Paul
• Format: Journal Article
• Language: English
• Published: United States Baishideng Publishing Group Inc 26-02-2016
• Subjects: Congenital; disease;Genetics;Genetic; heart; Review; screening;Genetic; testing; Genetics; Congenital heart disease; Genetic testing; Genetic screening
• ISSN: 1949-8462; 1949-8462
• DOI: 10.4330/wjc.v8.i2.180

Congenital heart disease(CHD) is the most common type of birth defect. Traditionally, a polygenic model defined by the interaction of multiple genes and environmental factors was hypothesized to account for different forms of CHD. It is now understood that the contribution of genetics to CHD extends beyond a single unified paradigm. For example, monogenic models and chromosomal abnormalities have been associated with various syndromic and non-syndromic forms of CHD. In such instances, genetic investigation and testing may potentially play an important role in clinical care. A family tree with a detailed phenotypic description serves as the initial screening tool to identify potentially inherited defects and to guide further genetic investigation. The selection of a genetic test is contingent upon the particular diagnostic hypothesis generated by clinical examination. Genetic investigation in CHD may carry the potential to improve prognosis by yielding valuable information with regards to personalized medical care, confidence in the clinical diagnosis, and/or targeted patient followup. Moreover, genetic assessment may serve as a tool to predict recurrence risk, define the pattern of inheritance within a family, and evaluate the need for further family screening. In some circumstances, prenatal or preimplantation genetic screening could identify fetuses or embryos at high risk for CHD. Although genetics may appear to constitute a highly specialized sector of cardiology, basic knowledge regarding inheritance patterns, recurrence risks, and available screening and diagnostic tools, including their strengths and limitations, could assist the treating physician in providing sound counsel.